Welcome to
On Feet Nation
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers
Roots Analysis is pleased to announce the publication of its recent study, titled, “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.”
The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of HPAPIs and…
ContinueAdded by Kevin Doe on February 18, 2021 at 12:02am — No Comments
Roots Analysis has done a detailed study on “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020- 2030”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 300+ page report, which features 75+ figures and 150+ tables, please visit this link
Key Market Insights
Close to 120 companies across the globe claim to possess the required expertise and infrastructure to offer contract manufacturing services…
Added by Kevin Doe on February 18, 2021 at 12:01am — No Comments
Although hazardous reaction chemistries are not used during early drug development stages owing to the associated risks, they offer a wide range of benefits over traditional approaches, especially from the perspective of large-scale manufacturing
Roots Analysis is pleased to announce the publication of its recent study, titled, “High Energy Chemistry / Hazardous Chemistry-based API Manufacturing Services Market: Focus on High Temperature, Low Temperature / Cryogenic, High Pressure and…
ContinueAdded by Kevin Doe on February 18, 2021 at 12:00am — No Comments
The High Energy Chemistry / Hazardous Chemistry- based API manufacturing services market is projected to grow at an annualized rate of ~8%, till 2030
Roots Analysis has done a detailed study on High Energy Chemistry / Hazardous Chemistry-based API Manufacturing Services Market: Focus on High Temperature, Low Temperature / Cryogenic, High Pressure and Low Pressure Chemistries, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth…
ContinueAdded by Kevin Doe on February 18, 2021 at 12:00am — No Comments
The anticipated growth in global diabetic patient population is likely to result in a significant rise in demand for novel, safe and more patient friendly drug delivery solutions for diabetics who are required to medicate on a frequent basis
Roots Analysis has announced the addition of “Diabetes Drug Delivery Devices Market, 2020-2030” report to its list of offerings.
Stakeholders engaged in this domain are presently focusing on introducing advanced features, such as integrated…
ContinueAdded by Kevin Doe on February 17, 2021 at 2:01am — No Comments
Stakeholders engaged in this domain are presently focusing on introducing advanced features, such as integrated continuous glucose monitoring (CGM) systems, artificial intelligence (AI) enabled algorithms, provisions for audiovisual / tactile feedback, and automatic drug reconstitution features. Such efforts are primarily directed towards differentiating proprietary offerings within a highlight competitive market landscape, and are expected to drive the market’s growth over the coming…
ContinueAdded by Kevin Doe on February 17, 2021 at 2:01am — No Comments
The “Diabetes Drug Delivery Devices Market, 2020-2030” report features an extensive study of the current market landscape and the likely adoption of diabetes drug delivery devices, over the next decade. The study features a detailed analysis of the key drivers and trends related to this evolving domain.
To order this 240+ page report, please visit this link
Key Inclusions
An overview of the current market landscape of diabetes drug delivery devices available for delivery…
Added by Kevin Doe on February 17, 2021 at 2:00am — No Comments
Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations. Consequently, a number of drug manufacturers have demonstrated a preference for outsourcing fill / finish operations of such products.
To order this 480+ page report, which features 350+ figures and 260+ tables, please visit this link
The USD 4.2…
ContinueAdded by Kevin Doe on February 17, 2021 at 2:00am — No Comments
To order this detailed 480+ page report, please visit this link
Key Inclusions
A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory), type of therapeutic modality used (monoclonal antibody, antibody fragment, small molecule and others), route of…
Added by Kevin Doe on February 17, 2021 at 2:00am — No Comments
A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety
Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.”
The report features an extensive study on the contract service providers offering drug product manufacturing services within the…
ContinueAdded by Kevin Doe on February 17, 2021 at 1:59am — No Comments
To order this detailed 370+ page report, please visit this link
Key Inclusions
A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies, featuring details on immuno-oncology biomarkers and disease indications being investigated, based on trial registration year, phase of development, recruitment status, therapy design and type of cancer therapy.
An analysis of the landscape of companies offering testing services for…
Added by Kevin Doe on January 29, 2021 at 12:23am — No Comments
Over time, pharmaceutical players have demonstrated significant interest in this domain and have launched clinical research initiatives to investigate the relevance and applications of these novel biomarkers. Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.
To order this 370+ page report, which features 190+ figures and 180+ tables,…
ContinueAdded by Kevin Doe on January 29, 2021 at 12:15am — No Comments
Roots Analysis has done a detailed study on Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030, covering key aspects of the industry and identifying key future growth opportunities.
To order this 370+ page report, which features 190+ figures and 180+ tables, please visit this link
Key Market Insights
Several novel biomarkers are presently under investigation for a variety of cancer indications; the initiatives of big pharmaceutical companies…
Added by Kevin Doe on January 29, 2021 at 12:04am — No Comments
Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions
Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.”
The report features an extensive study of the current landscape and…
ContinueAdded by Kevin Doe on January 29, 2021 at 12:01am — No Comments
With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with the potential to be used as treatment options for a variety of disease indications. Several pipeline candidates have recently entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.
To order this 370+ page report, which features 90+ figures and 110+ tables, please…
ContinueAdded by Kevin Doe on January 28, 2021 at 11:32pm — No Comments
Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 370+ page report, which features 90+ figures and 110+ tables, please visit this link
Key Market Insights
With two approved drugs and close to 300 clinical / preclinical product candidates, the bispecific antibody therapeutics pipeline has evolved…
Added by Kevin Doe on January 28, 2021 at 11:20pm — No Comments
Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community
Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030.”
The report features an extensive study of the current market landscape, offering an…
ContinueAdded by Kevin Doe on January 28, 2021 at 11:12pm — No Comments
To order this 350+ page report, please visit this link
Key Inclusions
A detailed review of the overall landscape of the non-invasive cancer diagnostics market, featuring information on the developers of such products and analyses based on a number of relevant parameters, such as year of establishment, company size, geographical location, current development status of proprietary liquid biopsy test (under development, research use only, and available), type of product (assay…
Added by Kevin Doe on January 28, 2021 at 1:22am — No Comments
Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.
To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this link
The financial opportunity within the liquid biopsy and other non-invasive cancer diagnostics market has been analyzed across the…
ContinueAdded by Kevin Doe on January 28, 2021 at 1:14am — No Comments
Roots Analysis has done a detailed study on Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this link
Key Market Insights
Presently, nearly 300…
Added by Kevin Doe on January 28, 2021 at 1:02am — No Comments
© 2024 Created by PH the vintage. Powered by